Blarcamesine hydrochloride by Anavex Life Sciences for Infantile Spasm (West Syndrome): Likelihood of Approval
Pharmaceutical Technology
DECEMBER 4, 2023
Blarcamesine hydrochloride is under clinical development by Anavex Life Sciences and currently in Phase I for Infantile Spasm (West Syndrome).… …
Let's personalize your content